| Resources | Blog

Blog

T cells
October 19, 2021

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
Posted in Company Updates by Vineti

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
May 2, 2019

Commercial lessons for clinical-phase success, Part I: it all starts with collaboration

Posted in Commercial Scale by Heidi Hagen

In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...

Read More
April 30, 2019

Q1 update from Vineti

Posted in Company Updates by Amy DuRoss

As 2019 shapes up to be yet another landmark year for advanced therapies, Vineti is hard at work on our...

Read More
April 24, 2019

Supply chain management readiness, Part 1: strategy

Posted in Commercial Scale by Marc Puich

There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....

Read More
April 23, 2019

Cell therapy labels that work — pointers to keep your patient and your product in sync

Posted in Company Updates by Heidi Hagen

In cell therapy, smarter labeling means greater safety and speed. If you’re a cell therapy developer, you have a make-or-break...

Read More
April 23, 2019

Setting standards — three essential starting points

Posted in Company Updates by Amy DuRoss

Welcome to the Vineti blog! This is our first post, and we’re looking forward to sharing insights, perspectives and company updates here....

Read More